Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
37m
on MSN
Lilly to take Q3 IPR&D charge of $2.83B, or $3.08 per share
Eli Lilly (NYSE:LLY) said it plans to take a Q3 acquired in-process research and development, or IPR&D, charge of ...
59m
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Mexican mayor assassinated
Kemp suspends GA mayor
Milton becomes Category 5
Sex abuse case dismissed
Harris on '60 Minutes'
Tickets to climb to $5
Human life expectancy study
Vanderbilt, Arkansas fined
Ranger dies during rescue
Richest female musician
Ordered to open app store
NC voting rule changes
King named grand marshal
US overdose deaths drop
Grammy-winning singer dies
North Dakota wildfires
TX emergency abortion case
Names new school board
Athlete payments approval
Targeted by a cyberattack
Settles latest civil lawsuit
Israel expands offensive
Intel defensive briefings rise
SCOTUS denies appeal
Hera mission launched
Hamas backers sanctioned
Liquidation plan approved
IVF clinic's appeal rejected
US antitrust case advances
Win Nobel Prize in physics
Related topics
Mounjaro
Zepbound
Indiana
Feedback